Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Transitioning COVID-19 Product Distribution to the Commercial Market
Throughout the COVID-19 pandemic, the federal government has primarily coordinated response efforts with the support of the private sector to develop, produce and distribute vaccines, personal protective equipment (PPE) and therapeutics. While this public health crisis continues, government and private-sector stakeholders are already thinking about the expected transition of COVID-19 product distribution to the commercial market — which could happen as early as the first quarter of this year.
HDA Testifies at House Hearing on Healthcare Affordability
Today, HDA President and CEO Chester “Chip” Davis, Jr., testified before the House Energy and Commerce Health Subcommittee at a hearing on “Lowering Healthcare Costs: Examining the Healthcare Supply Chain.”
HDA Presents 2022 Distribution Management Award to AmerisourceBergen
The Healthcare Distribution Alliance (HDA) honored AmerisourceBergen with the 2022 Distribution Management Award (DMA) in recognition of the company’s collaboration with multiple government and supply chain partners to enable small-practice provider access to the COVID-19 vaccine. The award was presented during the 2022 Distribution Management Conference and Expo in Austin, Texas.
HDA Recognizes Pharmaceutical and Consumer Product Manufacturers With Diana Awards
The Healthcare Distribution Alliance (HDA) awarded 20 pharmaceutical and consumer product manufacturers with Distribution Industry Awards for Notable Achievements in Healthcare (DIANA Awards) at the 2024 HDA Business and Leadership Conference in Colorado Springs, Colo.